Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

14 results
Display

The Change of Cognitive Function after Administration of Tolterodine in Brain Disease Patients with Overactive Bladder

Kim TH, Park MJ, Cho WY

  • KMID: 2330967
  • J Korean Continence Soc.
  • 2008 Dec;12(2):133-138.
PUROPOSE: It is known that anticholinergics induces cognitive dysfunction and may aggravate the state of it. Tolterodine tartrate (detrusitol(R)) is a widely known selective anticholinergics to bladder, which does not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Tolerability of Tolterodine Compared to Oxybutynin in Children with a Neurogenic Bladder

Kim KM, Lee SW

  • KMID: 2294073
  • Korean J Urol.
  • 2005 Jun;46(6):598-603.
PURPOSE: The aim of this study was to investigate the efficacy and adverse effects of oral tolterodine compared to oxybutynin in children with a neurogenic bladder. MATERIALS AND METHODS: 16 patients,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Bladder Training, Tolterodine and Bladder Training with Tolterodine in Female Patients with Overactive Bladder: Prospective, Randomized Study

Park JT, Kim JB, Park SC, Song C, Choo MS

  • KMID: 2293344
  • Korean J Urol.
  • 2003 Apr;44(4):301-306.
PURPOSE: There are few reports concerning the first-line treatment of choice for an overactive bladder. The aim of this study was to compare the effects of bladder training, tolterodine, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of tolterodine Via Oral and Intravenous Administrations on Voiding in Awake Spontaneously Hypertensive Rats as an Overactive Bladder Model

Lee SY, Jin LH, Kwon YH, Jang JH, Kang YJ, Yoon SM, Lee T

  • KMID: 2331556
  • J Korean Continence Soc.
  • 2009 Dec;13(2):152-158.
PURPOSE: We investigated the effect of oral or intravenous tolterodine on cystometric parameters in awake spontaneously hypertensive rats (SHRs) as a model of overactive bladder (OAB). The aim of our...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Tolterodine and Oxybutyninin on Nocturia in Patients with Benign Prostatic Hyperplasia

Gim JD, Seo YJ, Lee KS, Kim KH

  • KMID: 2331538
  • J Korean Continence Soc.
  • 2009 Jun;13(1):23-29.
PURPOSE: Nocturia has been one of the most bothersome symptoms in benign prostatic hyperplasia (BPH) patients. Therefore, the authors evaluated the effect of tolterodine and oxybutyninin on nocturia in BPH...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidence of Overactive Bladder in Benign Prostatic Hyperplasia and the Efficacy of Combination Therapy of Alpha Blocker with Tolterodine

Kim HW, Seo SI, Ko JS, Jung JH, Lee JY

  • KMID: 2293294
  • Korean J Urol.
  • 2003 Oct;44(10):1006-1010.
PURPOSE: The incidence of overactive bladder (OAB) and the efficacy of alpha blocker and tolterodine combination therapy were examined in patients with symptomatic benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of In Vivo Drug-Receptor Binding

Yamada S, Kuraoka S, Osano A, Ito Y

  • KMID: 2232961
  • Int Neurourol J.
  • 2012 Sep;16(3):107-115.
The in vivo muscarinic receptor binding of antimuscarinic agents (oxybutynin, solifenacin, tolterodine, and imidafenacin) used to treat urinary dysfunction in patients with overactive bladder is reviewed. Transdermal administration of oxybutynin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Review of the Anticholinergics for the Treatment of Overactive Bladder: 2009 Update

Oh SJ

  • KMID: 2331537
  • J Korean Continence Soc.
  • 2009 Jun;13(1):7-22.
Overactive bladder is a chronic condition defined by bothersome urgency with or without urgency incontinence, usually associated with daytime frequency and nocturia. The treatment of this condition is to control...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction

Jin LH, Park CS, Shin HY, Yoon SM, Lee T

  • KMID: 2232806
  • Int Neurourol J.
  • 2011 Sep;15(3):120-126.
PURPOSE: We investigated bladder function, with a special focus on nonvoiding contractions (NVCs), in awake rats with chronic chemical cystitis and bladder outlet obstruction (BOO) by use of simultaneous registrations...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Effects of Amitriptyline on the Nocturia of Patients with Benign Prostatic Hyperplasia

You SH, Jeong HJ

  • KMID: 2312002
  • Korean J Urol.
  • 2008 Apr;49(4):343-349.
PURPOSE: We evaluated the effects of amitiptyline, as one of the first-line therapies, on the nocturia of patients with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: Between June 2005 and December...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Local Effects of Antimuscarinics on Muscarinic Receptors in Bladder Sensory Nerves

Park MS, Cho SW, Han KH, Lee SC, Kim WJ, Kim YT

  • KMID: 2330522
  • J Korean Continence Soc.
  • 2006 Jun;10(1):17-22.
PURPOSE: To investigate the role of muscarinic receptors in bladder sensory mechanism. MATERIALS AND METHODS: Normal adult volunteers collected voided urine after taking five days of trospium(20 mg bid), tolterodine LA(4...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study on the Efficacy of Combination Therapy with Alpha-blockers and Anticholinergics in the Lower Urinary Tract Symptoms Patients Accompanied with Overactive Bladder Symptoms

Lee KC, Cho IR

  • KMID: 2330556
  • J Korean Continence Soc.
  • 2007 Jun;11(1):63-67.
PURPOSE: Benign prostatic hyperplasia(BPH) patients usually accompanies overactive bladder(OAB) symptoms. Adding anticholinergics in these patients evokes us worrying about deterioration of obstructive symptoms. We evaluated the relative benefit of anticholinergics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Stent Position Is More Important than alpha-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study

Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, Yang DY, Lee SK, Cho JS

  • KMID: 2314628
  • Korean J Urol.
  • 2010 Sep;51(9):636-641.
PURPOSE: To evaluate the clinical factors that impact ureteral stent-related lower urinary tract symptoms (LUTS) after ureteroscopic ureterolithotomy, including the stent position and medication. MATERIALS AND METHODS: Fifty-three patients who underwent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors

Hsiao SM, Liao CH, Lin HH, Kuo HC

PURPOSE: To determine the duration of antimuscarinic therapy for overactive bladder syndrome (OAB) appropriate for assessment of the efficacy of treatment, and to evaluate the possible predictive factors for response...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr